ArticleMaterials today. Bio2025
Cuttlefish ink nanoparticle-engineered hydrogel microspheres synergistically attenuate disc degeneration via antioxidant defense and matrix synthesis activation.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A biomimetic core-shell nanofibrous dressing for temporally coordinated infection control and mitochondrial protection in diabetic wounds.Materials today. Bio · 2026Article
- Supramolecular self-assembled polyphenol nanoparticles alleviate osteoarthritis by inhibiting chondrocyte ferroptosis.Materials today. Bio · 2026Article
- Fabrication and Functional Modification Strategies of Squid Ink-Derived Nanoparticles: From Natural Melanin to Multifunctional Biomaterials.Marine drugs · 2026Review
- Chondroitin sulfate reinforces mitochondrial redox homeostasis to enable integrated intervertebral disc regeneration.Regenerative biomaterials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intervertebral disc degeneration (IVDD) is a leading cause of spinal disorders, affecting millions globally, particularly the aging population. Current treatments, however, fail to fully restore disc structure and function, highlighting the need for regenerative therapies. This study aims to construct an antioxidant artificial nucleus pulposus (NP) by incorporating cuttlefish ink nanoparticles (CINPs) into GelMA microspheres, thereby enhancing nucleus pulposus cell (NPC) viability and extracellular matrix (ECM) synthesis. Oxidative stress is a key driver of disc degeneration. CINPs, rich in proline and fucose, significantly enhanced the antioxidant capacity of NPCs, as evidenced by reduced intracellular reactive oxygen species (ROS) levels and activation of the nuclear factor erythroid 2-related factor 2/heme oxygenase-1 (NRF2/HO-1) pathway in our study. In vitro experiments demonstrated that GelMA@CINPs microspheres significantly enhanced NPC antioxidant capacity and promoted ECM secretion. Implantation of these microspheres into intervertebral discs (IVDs) of rats following discectomy validated their therapeutic efficacy in promoting NP tissue regeneration. In this experiment, the introduction of CINPs facilitates a dual antioxidant mechanism, comprising chemical (e.g., free radical scavenging by eumelanin via HAT/SET mechanisms) and biological (activation of the NRF2/HO-1 pathway) components. This synergistic approach directly addresses oxidative stress, a critical driver of intervertebral disc degeneration (IVDD) progression. This research introduces a novel strategy for improving cell-material interactions in tissue engineering, which enhances the potential for constructing an artificial NP and effectively treating IVDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.